Levonoble A Tablet is a combination medication containing Levocetirizine (5mg) and Ambroxol (60mg), which work together to provide relief from symptoms associated with respiratory and allergic conditions. Levocetirizine is a second-generation antihistamine that effectively blocks histamine receptors, reducing the symptoms of allergies, such as sneezing, itching, and runny nose. Ambroxol, on the other hand, is a mucolytic agent that helps in breaking down mucus, making it easier to clear from the airways.
This dual-action formulation is particularly useful for individuals suffering from allergic rhinitis and respiratory conditions that involve excessive mucus production, such as chronic bronchitis or chronic obstructive pulmonary disease (COPD). By combining an antihistamine with a mucolytic, Levonoble A Tablet not only addresses the allergy-related symptoms but also helps in managing respiratory congestion and excessive mucus accumulation, leading to easier breathing and better airflow.
Levonoble A Tablet is effective in treating allergic rhinitis (hay fever) and can help manage symptoms like sneezing, nasal congestion, runny nose, and itchy or watery eyes. Additionally, the presence of Ambroxol makes it beneficial for individuals dealing with respiratory tract infections, reducing mucus viscosity, and easing its expectoration. This makes the tablet an excellent choice for people who need relief from both allergy and respiratory symptoms.
The medication should be taken as prescribed by a healthcare provider, usually once daily, depending on the severity of symptoms. It is recommended to take the tablet with food or as directed to ensure maximum efficacy and minimize potential gastrointestinal irritation. The tablet is designed to provide long-lasting relief, allowing individuals to return to their normal activities with minimal disruption from allergy or respiratory symptoms.